These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 5613110)
1. [The effect of heparin on the blood coagulation system in patients with thromboembolic disease of the retinal vessels]. Efetova TM Oftalmol Zh; 1967; 22(4):258-61. PubMed ID: 5613110 [No Abstract] [Full Text] [Related]
2. [Prolonged ambulatory anticoagulant treatment of patients with thromboembolic lesions of the retinal vessels]. Efetova TM Oftalmol Zh; 1968; 23(8):604-7. PubMed ID: 5747458 [No Abstract] [Full Text] [Related]
5. [Thrombosamine-heparin in retinal vascular obliterations]. Antoine F; Mendelsohn P Bull Soc Ophtalmol Fr; 1965; 65(7):627-30. PubMed ID: 5844754 [No Abstract] [Full Text] [Related]
6. Treatment of thrombosis of the central retinal vein with streptokinase. den Ottolander GJ; Craandijk A Thromb Diath Haemorrh; 1968 Dec; 20(3):415-9. PubMed ID: 5710463 [No Abstract] [Full Text] [Related]
7. [Evaluation of heparin therapy: sensitivity of the various methods]. Merino J; González-Boullosa R; Benet I; García-Conde J Rev Clin Esp; 1978 Oct; 151(2):107-11. PubMed ID: 740979 [No Abstract] [Full Text] [Related]
8. [Use of calcium heparinate in anticoagulant therapy]. Vivien P; Allannic H; Loussouarn J; Turpin J Therapie; 1971; 26(1):141-8. PubMed ID: 5554761 [No Abstract] [Full Text] [Related]
9. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients]. Zabolotskikh IB; Sin'kov SV; Klevko VA Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909 [No Abstract] [Full Text] [Related]
10. [Anticoagulant treatment with heparin]. Langer B; Wolosker M; Albers MT Rev Paul Med; 1982; 99(1):31-2. PubMed ID: 7146741 [No Abstract] [Full Text] [Related]
11. Recent advances in heparin structure, function and clinical usage. Fussi F Boll Chim Farm; 1978 Oct; 117(10):561-74. PubMed ID: 743352 [No Abstract] [Full Text] [Related]
12. [Inhibition of plasmatic coagulation: what is new?]. Schwarz M; Bode C Hamostaseologie; 2006 May; 26(2):154-7. PubMed ID: 16676059 [TBL] [Abstract][Full Text] [Related]
13. [Prevention of thromboembolic complications in cancer patients]. Kapatsinskiĭ EV Sov Med; 1983; (4):69-72. PubMed ID: 6867836 [No Abstract] [Full Text] [Related]
14. Sources of error in heparin therapy of thromboembolic disease. Hattersley PG; Mitsuoka JC; King JH Arch Intern Med; 1980 Sep; 140(9):1173-5. PubMed ID: 7406615 [TBL] [Abstract][Full Text] [Related]
15. [Thromboembolic disease of long standing with hyperfibrinogenemia. Treatment with heparin, magnesium and anti-inflammatory agent]. Cristau P; Hainaut J; Molinie C; Essioux H; Pariente A; Florent C; Laverdant C Ann Med Interne (Paris); 1977 Nov; 128(11):887-94. PubMed ID: 563206 [No Abstract] [Full Text] [Related]